Cellectis (CLLS) - Shares outstanding

Number of shares outstanding as of July 2026 : 100,527,276

According to Cellectis's latest financial reports and stock price the company's current number of shares outstanding is 100,527,276. At the end of 2026 the company had 100,527,276 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Cellectis from 2015 to 2026

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2026	0.10 B	0.2%
2025	0.10 B	0.23%
2024	0.10 B	80.08%
2023	55.58 M	22.3%
2022	45.44 M	6.33%
2021	42.74 M	0.36%
2020	42.58 M	0.32%
2019	42.45 M	0.05%
2018	42.43 M	18.03%
2017	35.94 M	1.74%
2016	35.33 M	0.59%
2015	35.12 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Regeneron Pharmaceuticals REGN	104,000,000	3.45%	🇺🇸 USA
uniQure QURE	62,742,847	-37.59%	🇳🇱 Netherlands
Novavax NVAX	163,276,000	62.42%	🇺🇸 USA
Flexion Therapeutics FLXN	38,562,800	-61.64%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Cellectis (CLLS)

Number of shares outstanding as of July 2026 : 100,527,276